AstraZeneca: News
28 Nov 2024
DiabetesNew drug offers breakthrough in Asthma, COPD treatment in 50-years
A new clinical trial has unveiled a promising way to treat severe asthma and chronic obstructive pulmonary disease (COPD) attacks.
16 Sep 2024
Health & WellnessThis drug shows promise in extending bladder cancer patients' lives
AstraZeneca's Imfinzi drug has shown significant potential in prolonging lives of patients with bladder cancer.
20 May 2024
Indian Council of Medical Research (ICMR)'Poor methodology': ICMR dissociates itself from Covaxin safety study
The Indian Council of Medical Research has disassociated itself from a Covaxin vaccine study conducted by the Banaras Hindu University (BHU).
17 May 2024
COVAXINAfter Covishield, new study finds side effects in Covaxin recipients
A recent study published in Springer Nature revealed that over 30% of Covaxin recipients reported "adverse events of special interest" (AESI).
16 May 2024
AustraliaAstraZeneca COVID vaccine linked to another rare blood clotting disorder
A new research has linked AstraZeneca's COVID-19 vaccine to an increased risk of a rare but fatal blood clotting disorder known as Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
08 May 2024
COVID-19AstraZeneca says it will withdraw Covid-19 vaccine globally
The United Kingdom-based pharmaceutical company, AstraZeneca, on Tuesday said that it has initiated a worldwide recall of Covid-19 vaccine.
02 May 2024
COVID-19Should I be worried if I have taken AstraZeneca's Covishield?
AstraZeneca, the pharmaceutical company behind the Covishield COVID-19 vaccine, recently acknowledged the potential risk of Thrombosis with Thrombocytopenia Syndrome (TTS) as a side effect.
01 May 2024
CovishieldAstrazeneca upholds vaccine safety amid health concerns
AstraZeneca has reaffirmed its dedication to patient safety amid reports of rare side effects from the AstraZeneca-Oxford COVID-19 vaccine.
30 Apr 2024
COVID-19Explained: What's TTS, rare condition caused by AstraZeneca's Covishield vaccine
In a significant development, AstraZeneca, the manufacturer of the Covishield vaccine, has acknowledged in legal documents that its vaccine may trigger a rare side effect known as Thrombosis with Thrombocytopenia Syndrome (TTS).
17 Dec 2021
United States of AmericaAstraZeneca's antibody cocktail Evusheld effective against Omicron, finds study
AstraZeneca COVID-19 antibody cocktail, Evusheld, effectively works against the Omicron variant of coronavirus, the company said Thursday citing a lab study.
03 Dec 2021
PfizerCOVID-19 vaccine: Study finds AstraZeneca booster jab safe, effective
Seven COVID-19 vaccines are safe and stimulate a strong immune response when used as a booster jab to those who have already vaccinated, a study published in The Lancet said.
03 Sep 2021
North KoreaKim orders tougher virus steps after North Korea shuns vaccines
North Korean leader Kim Jong Un ordered officials to wage a tougher epidemic prevention campaign after he turned down some foreign COVID-19 vaccines offered via the UN-backed immunization program.
05 Aug 2021
Oxford UniversityCOVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll
Mattel, the maker of the Barbie doll, has created a doll to honor Professor Sarah Gilbert, who led the development of the Oxford University and AstraZeneca COVID-19 vaccine.
04 Aug 2021
COVID-19India mulls mixing Covishield, Sputnik doses; no recommendation yet
India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.
17 Jul 2021
FranceFrance allows visitors vaccinated with Indian-made AstraZeneca vaccine
France will now allow international travelers who have received AstraZeneca's Indian-manufactured vaccine into the country starting Sunday.
02 Jul 2021
IndiaMix-and-match COVID-19 vaccines: What do studies say?
In most coronavirus vaccination regimes, two doses of the same brand are given a few weeks apart.
24 Jun 2021
PfizerSingle dose of Pfizer, AstraZeneca vaccines offers 60 percent protection
A single dose of Pfizer or AstraZeneca COVID-19 vaccine offers around 60 percent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
19 Jun 2021
World Health OrganizationEfforts on to restart AstraZeneca shipments from India: WHO official
The WHO is urgently trying to work with AstraZeneca, Serum Institute of India (SII) as well as the Indian government to restart shipments of COVID-19 vaccines to countries, a senior official at the UN health agency said.
15 Jun 2021
PfizerPfizer, AstraZeneca vaccines protect against Delta variant, says study
Pfizer and AstraZeneca vaccines provide good protection against the Delta variant of coronavirus, first identified in India, says a study published in The Lancet Journal.
10 Jun 2021
COVID-19 VaccineAstraZeneca vaccine linked to small risk of low blood platelets
The Oxford-AstraZeneca vaccine, known in India as Covishield, may be associated with a small risk of developing a blood condition characterized by low platelet counts, according to a UK study.
21 May 2021
EnglandTwo doses of AstraZeneca vaccine 85%-90% effective, real-world data shows
Two doses of the Oxford/AstraZeneca COVID-19 vaccine are around 85 percent to 90 percent effective against the symptomatic disease, Public Health England (PHE) has said, citing a new analysis of real-world data from the roll-out of the shot in the UK.
11 May 2021
PfizerAstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said on Monday, citing data from the vaccine's rollout.
02 May 2021
VaccineCOVID-19 vaccine formulas shouldn't be shared with India: Bill Gates
It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.
15 Apr 2021
DenmarkDenmark becomes first European country to permanently drop AstraZeneca vaccine
Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.
08 Apr 2021
Serum Institute of IndiaAstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
03 Apr 2021
COVID-19 VaccinationUK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients
On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.
02 Apr 2021
Sri LankaFacing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs
Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.
31 Mar 2021
GermanyGermany halts AstraZeneca vaccine use for under-60s over clot fears
Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.
25 Mar 2021
VaccineAmid growing cases, India temporarily halts export of AstraZeneca's vaccine
Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.
22 Mar 2021
CoronavirusAstraZeneca says US trial data shows vaccine 79% effective
AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.
19 Mar 2021
EuropeAstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination
A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.
16 Mar 2021
ItalyWhy European countries are halting the AstraZeneca shot
The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.
13 Mar 2021
IndiaLooking at adverse effects: India on concerns over AstraZeneca vaccine
India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.
12 Mar 2021
DenmarkUse of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland
Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.
01 Mar 2021
CoronavirusAstraZeneca has sold its stake in Moderna for $1 billion
British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.
25 Feb 2021
Serum Institute of IndiaCOVID-19 vaccines: SII to play huge role in mass production
British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
16 Feb 2021
World Health OrganizationWHO authorizes AstraZeneca's COVID-19 vaccine for emergency use
The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.
10 Feb 2021
South AfricaSouth Africa scraps AstraZeneca vaccine, will give J&J jabs
South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.
04 Feb 2021
PfizerUK begins world's first alternate dosing COVID-19 vaccine trial
Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
03 Feb 2021
CoronavirusOxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study
According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.
03 Feb 2021
PfizerRussia's coronavirus vaccine approved for use in Mexico
Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.
02 Feb 2021
PfizerSouth Africa welcomes first delivery of COVID-19 vaccines
South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.
30 Jan 2021
Narendra ModiSri Lanka: No adverse reactions so far following vaccination
No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.
11 Jan 2021
VaccineVaccine transport from SII to start from January 11/12
With the COVID-19 vaccination drive in India set to roll out on January 16, transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, is likely to start from the evening of January 11 or January 12, sources involved in logistics planning said on Sunday.
04 Jan 2021
Ministry of Health and Family WelfareCOVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."
31 Dec 2020
IndiaUK's approval to Oxford-AstraZeneca vaccine paves way for India
The United Kingdom on Wednesday approved the vaccine developed by Oxford University and the British-Swedish pharmaceutical company AstraZeneca, giving the vaccine an endorsement that will likely be considered by Indian drug regulators.
30 Dec 2020
Oxford UniversityAfter Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom.
28 Dec 2020
Oxford UniversityOxford/AstraZeneca vaccine should be effective against new variant: Report
The coronavirus vaccine developed by Oxford University and AstraZeneca should be effective against the highly transmissible new strain of the virus, a UK media report said on Sunday.
23 Dec 2020
IndiaAwaiting COVID-19 vaccine arrival, Delhi hospital working on storage facility
From installing freezers to cold chain equipment set up, arrangements are being made at a Delhi government hospital for storage of the COVID-19 vaccine, anticipating its arrival, sources said on Tuesday.
23 Dec 2020
IndiaIndian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week
The coronavirus vaccine, developed by the University of Oxford and AstraZeneca, is likely to get approval from the Indian government for emergency use by next week, two people privy to the development told Reuters.
22 Dec 2020
Vladimir PutinRussia, AstraZeneca to test combination of COVID-19 shots
Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.
12 Dec 2020
Times of IndiaHere's how the government is planning to conduct COVID-19 vaccinations
With licensing for COVID-19 vaccines expected in the coming weeks, the government has drafted a plan for vaccination campaigns.
Trial will continue: Centre on SII vaccine's "adverse reaction" claims
With the coronavirus vaccine trials being conducted by Serum Institute of India (SII) being shrouded in controversy after a participant complained of an "adverse reaction," the Centre on Tuesday said there's no need to stop the process.
30 Nov 2020
OxfordSII to sue vaccine trial participant for Rs. 100 crore
The Serum Institute of India (SII) has said that it will seek Rs. 100 crore in damages from a COVID-19 vaccine trial participant for complaining about side-effects.
26 Nov 2020
OxfordManufacturing error in Oxford-AstraZeneca coronavirus vaccine raises pertinent questions
After announcing that their coronavirus vaccine candidate was nearly 70% effective, the University of Oxford and its partner, AstraZeneca, on Wednesday admitted to a manufacturing error, which has now sparked important questions about the results.
23 Nov 2020
OxfordOxford's vaccine, India's best shot against coronavirus, is 70% effective
The coronavirus vaccine being developed by Oxford University and British pharma giant AstraZeneca is 70% effective, results from large-scale trials have shown, multiple reports said on Monday.
22 Nov 2020
Indian Council of Medical Research (ICMR)Bharat Biotech vaccine trials continued despite 'adverse event' in August
Hyderabad-based biotechnology firm Bharat Biotech has issued a statement confirming that an "adverse event" had taken place during the Phase I trials of its COVID-19 vaccine candidate COVAXIN.
08 Nov 2020
Serum Institute of IndiaVaccine tracker: Covishield trials running smoothly; COVAXIN expected by February
Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.
05 Nov 2020
IndiaAffordable COVID-19 vaccine by January 2021, promises SII's Adar Poonawalla
Adar Poonawalla, the CEO of Serum Institute of India, said that the vaccine against coronavirus will be available in India by January 2021, two months from now, provided that the government gives approvals on time.
01 Nov 2020
CoronavirusVaccine tracker: Covishield expected by December; Moderna readies for launch
It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.
26 Oct 2020
OxfordOxford COVID-19 vaccine generates immune response among young and old
The COVID-19 vaccine being developed by Oxford University and AstraZeneca generates similar immune responses among younger and older adults, the pharmaceutical company has said.
22 Oct 2020
OxfordAstraZeneca COVID-19 vaccine trial's volunteer dies, testing to continue
A volunteer involved with the trial of coronavirus vaccine developed by AstraZeneca and Oxford University has died, Brazil's health authority Anvisa informed on Wednesday.
20 Oct 2020
VaccineIndia to play crucial role in COVID-19 vaccine process
As the world's largest vaccine manufacturer, India will play a major role in the vaccination efforts for COVID-19.
13 Oct 2020
Johnson & JohnsonBig setback: Johnson & Johnson pauses coronavirus vaccine trial
Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.
24 Sep 2020
World Health OrganizationUK planning "challenge trials" that deliberately expose volunteers to COVID-19
With the world waiting for a coronavirus vaccine with bated breath, the United Kingdom is looking to launch an unusual trial — one wherein volunteers would be intentionally infected with the virus to judge how effective a vaccine is.
12 Sep 2020
VaccineAstraZeneca resumes clinical trials for COVID-19 vaccine after UK nod
Late-stage clinical trials of a COVID-19 vaccine being developed by the drug firm AstraZeneca and the University of Oxford have resumed.
12 Sep 2020
VaccineCoronavirus: Serum Institute ordered to halt recruitment for vaccine trial
The Drugs Controller General of India (DCGI) has ordered the Serum Institute of India (SII) to pause the recruitment of volunteers for Phase 2 and Phase 3 trials of the coronavirus vaccine, being developed by the University of Oxford and UK-pharma giant AstraZeneca.
10 Sep 2020
OxfordBig setback: Serum pauses Oxford's coronavirus vaccine trial in India
A day after deciding to not halt the trial of the coronavirus vaccine, developed by the University of Oxford in collaboration with UK-pharma giant AstraZeneca, the Serum Institute of India (SII) on Thursday said it was also pausing the process.
10 Sep 2020
University of OxfordSerum Institute gets notice after AstraZeneca halts coronavirus vaccine trial
Drug Controller General of India (DCGI) sent a notice to the Serum Institute of India (SII) asking why trials for the coronavirus vaccine candidate, developed by the University of Oxford, were not halted even when UK-based pharma giant AstraZeneca had stopped the process after a volunteer fell ill.
09 Sep 2020
United KingdomAstraZeneca halts coronavirus vaccine trial after volunteer falls ill
Pharmaceutical giant AstraZeneca announced on Tuesday that it was halting late-stage trials of the coronavirus vaccine, developed in collaboration with the University of Oxford, after a volunteer fell ill.
04 Sep 2020
Pfizer#VaccineTracker: Early COVID-19 vaccine results expected by September 15
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
27 Aug 2020
Oxford UniversityCoronavirus vaccine tracker: When will one be ready?
The global effort to develop a vaccine against the novel coronavirus SARS-CoV-2 continues as over 24 million people have been infected worldwide.
30 Jul 2020
VaccineCoronavirus: How much would the vaccines cost?
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.
24 Jul 2020
Oxford UniversityMeet Adar Poonawalla, the man bringing COVID-19 vaccines to India
In the fight against COVID-19, or should we say the worst health crisis of our time, several institutes/organizations are racing to develop vaccines, anti-viral treatments.
22 Jul 2020
PfizerAs coronavirus pandemic surges, some vaccine makers expect to profit
Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.
17 Jul 2020
Oxford#GoodNews: Oxford's COVID-19 vaccine may be available by September-end
The COVID-19 vaccine developed by researchers at Oxford University in partnership with AstraZeneca generates an immune response against the infection in humans, The Telegraph reports.
07 Jun 2020
OxfordCOVID-19 vaccine: What are the latest updates?
With a sporadic increase in the number of cases and deaths, COVID-19 is growing beyond control in India.
